EZH2 modulates mRNA splicing and exerts part of its oncogenic function through repression of splicing factors in CML.
Brunmeir R, Ying L, Yan J, Hee YT, Lin B, Kaur H, Leong QZ, Teo WW, Choong G, Jen WY, Koh LP, Tan LK, Chan E, Ooi M, Yang H, Chng WJ.
Brunmeir R, et al. Among authors: tan lk.
Leukemia. 2025 Jan 7. doi: 10.1038/s41375-024-02509-y. Online ahead of print.
Leukemia. 2025.
PMID: 39774797